Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance

JAKARTA, Indonesia, July 26, 2022 /PRNewswire/ -- Centrient Pharmaceuticals, a global business-to-business leader in sustainable, enzymatic antibiotics manufacturing, in partnership with Menjangan Sakti, a trader of pharmaceutical raw materials inIndonesia, organized a workshop on 'Sustainability...

2022-07-26 21:45 1951

ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW

Company receives top customer rating in the 2022 IMV ServiceTrak™ Awards SAN DIEGO, July 26, 2022 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary,Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and service...

2022-07-26 21:35 1907

Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America

The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo inChicago. CHICAGO, July 26, 2022 /PRNewswire/ -- Menarini Silicon Biosystems Inc, a US...

2022-07-26 21:00 1727

Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus

SINGAPORE, July 26, 2022 /PRNewswire/ -- Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus (MPXV), for research use only (RUO). The ViroKey® MPXV PCR Test allows for the prompt, in vitro detection of MPXV DNA from human skin lesion specimens. It is com...

2022-07-26 21:00 1921

Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan

* Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents inJapan GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious d...

2022-07-26 20:05 2096

Henlius HANQUYOU Received TGA Approval in Australia

SHANGHAI, July 26, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner Cipla Limited ("Cipla") has received the relevant registration certificates from the Therapeutic Goods Administration ofAustralia ("TGA") for the approval of Henlius' sel...

2022-07-26 18:03 2645

Sirnaomics Receives IND Clearance from the "Taiwan Ministry of Health and Welfare" for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment

GAITHERSBURG, Md. and SUZHOU, China, July 26, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company has received regulatory clearance from t...

2022-07-26 16:58 2148

Intellect partners with Swiss Life Network to expand reach of comprehensive mental health care solutions in Asia

* Intellect joins hands with leading global employee benefits providers, Swiss Life Network * This partnership brings Intellect's comprehensive mental health solutions to workforces across APAC through Swiss Life Network's Clients and Network Partners SINGAPORE, July 26, 2022 /PRNewswire/ -- ...

2022-07-26 15:52 2642

Manulife enhances Cashless Day Surgery eService to diversify its comprehensive healthcare support

Expansion of specialist network, medical service providers, and categories of surgeries under eight major specialties offers customers more convenient quality health services HONG KONG, July 26, 2022 /PRNewswire/ -- Manulife Hong Kong today announced it has enhanced its Cashless Day Surgery eSer...

2022-07-26 12:33 3208

Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform

EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell ...

2022-07-26 11:51 1840

Largest-Ever Industry Report Reveals Video Meetings 3x More Effective and Companies Using Them Most Gain Advantage

Data from over 130 million quarterly HCP-field interactions across 80% of global biotech and pharma companies unveiled in Veeva Pulse Field Trends Report Industrywide data shows frequent use of key digital channels is vital for effective HCP engagement PLEASANTON, Calif., July 26, 2022 /PRNewswi...

2022-07-26 09:17 1818

Clinivate Provides Notice Of Data Security Incident

PASADENA, Calif., July 26, 2022 /PRNewswire/ -- Nationwide – Clinivate, LLC ("Clinivate") recently experienced a data security incident that may have involved the protected health information of individuals within Clinivate's electronic health record system. OnJuly 22, 2022, Clinivate sent letter...

2022-07-26 08:59 1555

Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong

Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI®, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ -- Singapore-based diagnostics developer and med...

2022-07-26 08:30 2379

Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong

Medicap Welcomes Two Malaysian Sportswomen as Brand Ambassadors

PUCHONG, Malaysia, July 26, 2022 /PRNewswire/ -- Malaysian healthcare company, Medicap , recently welcomed national wushu athlete Tan Cheong Min and table tennis player Ho Ying as their brand ambassadors for 2022-2024.

2022-07-26 08:00 2009

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive innovation and solution development MONROE, Ohio, July 26, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced...

2022-07-26 03:35 2277

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform

* Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissues * Rona licensed Sanofi's siRNA platform to enable discovery programs in expanded therapeutic areas including neuro and muscular diseases, for which Sanofi has an exclusive option to acquire neu...

2022-07-25 12:30 2223

Qiming's Portfolio Company InventisBio Lists on STAR Market

SHANGHAI, July 25, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange. The issue price isCNY 18...

2022-07-25 11:55 3488

Biotech Company RemeGen Commemorates International Self-Care Day with Health Initiatives

YANTAI, China, July 25, 2022 /PRNewswire/ -- The 24th of July marks International Self Care Day, highlighting self-care as an essential component of wellness. On this special day, RemeGen Co., Ltd. (9995.HK, SHA: 688331), a commercial-stage biotechnology company, advocates an active and healthy ...

2022-07-25 11:00 1801

Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings

Early Detection Can Prevent 95% of Vision Loss Cases SEOUL, South Korea, July 25, 2022 /PRNewswire/ -- Diabetic retinopathy is the leading cause of blindness among working-age adults globally.1 With early detection and treatment, as much as 95 percent of vision loss cases can be prevented.2 Com...

2022-07-25 08:30 2386

Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings

US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL

* Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical trial investigating tigilanol tiglate in the treatment of patients with Soft Tissue Sarcoma (STS) * The open label trial will evaluate efficacy and dose ranging in patients with advanced or metasta...

2022-07-25 07:09 2152

1 ... 180 181 182183184 185 186 ... 554